Atherosclerosis and diabetes Circulatory System Atherosclerosis and diabetes
Conditions
Interventions
Patients enrolled in the study will undergo a metabolic assessment at baseline to evaluate the degree of glucose impairment.
The basal metabolic assessment include:
1. Fasting plasma glucose, fastin
Sponsors
University of Rome Tor Vergata Department of Systems Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients were diagnosed with established and documented atherosclerotic vascular disease at the atherosclerosis ambulatory clinic that includes cardiology, diabetology and vascular surgery specialists. All the patients have had a major CV event or undergone a vascular procedure for significant vascular stenosis.
Exclusion criteria
Exclusion criteria: 1. Liver disease 2. Renal insufficiency 3. Heart failure 4. Coagulopathy 5. Any other severe systemic disease 6. Positive blood tests for HIV, hepatitis B, or hepatitis C
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Mortality is measured using the phone interview confirmed by hospital records at yearly follow-up 2. Cardiovascular mortality is measured using the phone interview confirmed by hospital records at yearly follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Non-fatal cardiovascular events (AMI and Stroke) are measured using the phone interview confirmed by hospital records at yearly follow-up. | — |
Countries
Italy
Outcome results
None listed